Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | TYROSINE (M-H)- | 16983 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TYROSINE (M-H)- | 18119 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TYROSINE (M-H)- | 22934 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TYROSINE (M-H)- | 29659 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TYROSINE (M-H)- | 32185 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TYROSINE (M-H)- | 32419 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TYROSINE (M-H)- | 35489 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TYROSINE (M-H)- | 38974 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TYROSINE (M-H)- | 39030 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TYROSINE (M-H)- | 40419 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TYROSINE (M-H)- | 41342 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TYROSINE (M-H)- | 48167 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TYROSINE (M-H)- | 52503 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TYROSINE (M-H)- | 61969 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+H)+ | 2606600 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+H)+ | 6676474 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+H)+ | 6793791 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+H)+ | 7848006 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+H)+ | 8470915 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+H)+ | 9958013 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+H)+ | 10100000 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+H)+ | 10300000 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+H)+ | 11000000 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+H)+ | 11200000 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+H)+ | 12900000 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+H)+ | 13400000 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+H)+ | 14300000 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+H)+ | 15300000 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+NA)+ | 93006 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+NA)+ | 108487 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+NA)+ | 118732 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+NA)+ | 131235 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+NA)+ | 137478 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+NA)+ | 161832 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+NA)+ | 176761 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+NA)+ | 200897 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+NA)+ | 229454 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+NA)+ | 282337 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+NA)+ | 338647 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+NA)+ | 369340 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TYROSINE (M+NA)+ | Peak area normalized | female | diabetic | Neuropathy | |
Reversed phase POSITIVE ION MODE | TYROSINE (M+NA)+ | Peak area normalized | female | diabetic | no neuropathy |